BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kasten BB, Ferrone S, Zinn KR, Buchsbaum DJ. B7-H3-targeted Radioimmunotherapy of Human Cancer. Curr Med Chem 2020;27:4016-38. [PMID: 30836909 DOI: 10.2174/0929867326666190228120908] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Flem-Karlsen K, Fodstad Ø, Nunes-Xavier CE. B7-H3 Immune Checkpoint Protein in Human Cancer. Curr Med Chem 2020;27:4062-86. [PMID: 31099317 DOI: 10.2174/0929867326666190517115515] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 9.5] [Reference Citation Analysis]
2 Grywalska E, Sobstyl M, Putowski L, Roliński J. Current Possibilities of Gynecologic Cancer Treatment with the Use of Immune Checkpoint Inhibitors. Int J Mol Sci 2019;20:E4705. [PMID: 31547532 DOI: 10.3390/ijms20194705] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 7.3] [Reference Citation Analysis]
3 Cherif B, Triki H, Charfi S, Bouzidi L, Kridis WB, Khanfir A, Chaabane K, Sellami-Boudawara T, Rebai A. Immune checkpoint molecules B7-H6 and PD-L1 co-pattern the tumor inflammatory microenvironment in human breast cancer. Sci Rep 2021;11:7550. [PMID: 33824367 DOI: 10.1038/s41598-021-87216-9] [Reference Citation Analysis]